Agilisium shifts Asia HQ to Hyderabad; eyes $500 mn revenue in 5-7 yrs
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓Agilisium announced on Tuesday that it will shift its Asia headquarters to Hyderabad.
- ✓The company aims to reach $500 million in revenue and hire 5,000 professionals over the next five to seven years.
- ✓Founder Raj Babu said, "Hyderabad has proven it can build global technology businesses and the city is well positioned."
Story at a Glance
- Category
- BUSINESS
- Reported By
- Business Standard
- Reading Speed
- 4 Minute(s)
- Market Focus
- India Economy
The company is on track to close 2026 with revenue of $72-75 million and cross $100 million in annual life sciences revenue in 2027 | Image: X@agilisium
Agilisium, a life sciences innovation and transformation company, on Tuesday announced plans to shift its Asia headquarters to Hyderabad, strengthening its presence in one of India's leading pharmaceutical and biotechnology hubs.
The company's current Asia headquarters is in Chennai. With Hyderabad joining Chennai and Pune as a core part of its operating footprint, Agilisium is targeting $500 million in revenue and plans to scale its workforce to approximately 5,000 specialised professionals over the next five to seven years.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
Business Standard
Read the full, original unfiltered story directly on the publisher's portal.